Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

2011375 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 377, Issue 9762, pp. 321-331

Field-Weighted Citation Impact: 30.77